Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700452 · ClinicalTrials.gov registry record
Diagnostic Study for Lung Cancer Detection Test
A clinical trial of Lung Cancer, sponsored by Bioview.
- Completed
- Registry status
- 173
- Enrollment target
- 6
- Study locations
NCT01700452: Completed study of Lung Cancer, sponsored by Bioview.
NCT01700452 is a study of Lung Cancer that has completed, run by Bioview. The registered enrollment target is 173 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (81% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01700452, a study of Lung Cancer, has completed, sponsored by Bioview.
- COMPLETED
- Registry status
- 173 participants
- Enrollment target
- 6
- Study locations
Study Summary
Early detection of lung cancer and early removal of the cancer nodules facilitates the diagnosis and treatment. However, not all nodules are malignant. Currently the standard method to diagnose lung cancer is to remove any suspicious nodules from the lung in a surgical procedure. This study is being conducted to evaluate the performance of a laboratory test to detect changes in lung cells that might be an early indicator of lung cancer. The test uses mucus (sputum) which is collected in a non-invasive method. This study will compare the results of the lung biopsy with the laboratory test to determine if the test can detect cancer or the lack of cancer. The laboratory test will not be shared with the treating physician or the patient as the current standard for lung cancer diagnosis is a biopsy. Approximately 330 patients will be enrolled in the study. There is one visit involved and includes the collection of a sputum specimen by coughing into a cup. The medical records of patients who are negative for cancer by biopsy will be reviewed for 2 years to detect any changes in diagnosis.
Primary Outcome
Subjects suspected of having of having lung cancer and who are to undergo biopsy will undergo sputum sampling. The sputum will be assayed using the BioView test kit. Biopsy results will be compared with the assay results, each being a dichotomous response (positive or negative for cancer by biopsy, positive or negative assay result using client-supplied cut-off). Since the assay may detect cancer before a biopsy is positive or because the sputum sampling may be more representative of the conditi
Conditions Studied
Study Locations (6)
Other
- Kaplan Medical Center - Rehovot
- Tel-Aviv Sourasky Medical Center - Tel Aviv
- Sheba Medical Center Thoracic Cancer Research and Detection Center - Tel Litwinsky
California
- VA Greater Los Angeles Health System - Los Angeles
Maryland
- Frederick Memorial Hospital, Regional Cancer Center - Frederick
Pennsylvania
- St. Luke's Hospital - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-04 |
What the finished NCT01700452 record still lists
NCT01700452 is an observational study that tracks outcomes without assigning an intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01700452 lists 6 locations in 4 states (Other, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT01700452 about?
NCT01700452 is a clinical study titled "Diagnostic Study for Lung Cancer Detection Test". Early detection of lung cancer and early removal of the cancer nodules facilitates the diagnosis and treatment. However, not all nodules are malignant. Currently the standard method to diagnose lung cancer is to remove any suspicious nodules from the lung in a surgical procedure. This study is bein...
What is the current status of trial NCT01700452?
This trial is currently completed. The enrollment target is 173 participants. The study started on 2012-04. Estimated completion is 2016-04.
What conditions does trial NCT01700452 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT01700452?
This trial is sponsored by Bioview, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01700452 being conducted?
This trial has 6 study locations across California, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01700452's enrollment target sits among peer trials
173 137th of 409 higher than 273 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia